Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tasker

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 25, 2015
Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitorsBin Wu, Hui-Ling Wang, Victor J Cee, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
N-Aryl-gamma-lactams as integrin alphavbeta3 antagonistsNing Xi, Stephen Arvedson, Shawn Eisenberg, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitorsHui-Ling Wang, Victor J Cee, Frank Chavez, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Ryan P Wurz, Shimin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitorsTae-Seong Kim, Andrew B Hague, Tony I Lee, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2012
Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groupsAnthony B Reed, Brian A Lanman, Susana Neira, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeuticsQingping Zeng, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|September 27, 2008
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Shimin Xu, Guo-Qiang Cao, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|January 25, 2015
Discovery of 5-(1H-indol-5-yl)-1,3,4-thiadiazol-2-amines as potent PIM inhibitorsBin Wu, Hui-Ling Wang, Victor J Cee, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2004
N-Aryl-gamma-lactams as integrin alphavbeta3 antagonistsNing Xi, Stephen Arvedson, Shawn Eisenberg, et al.
Bioorganic & Medicinal Chemistry Letters|January 19, 2015
The discovery of novel 3-(pyrazin-2-yl)-1H-indazoles as potent pan-Pim kinase inhibitorsHui-Ling Wang, Victor J Cee, Frank Chavez, et al.
Journal of Medicinal Chemistry|March 12, 2010
Discovery and evaluation of 7-alkyl-1,5-bis-aryl-pyrazolopyridinones as highly potent, selective, and orally efficacious inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Ryan P Wurz, Shimin Xu, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(4-Piperidinylphenyl)aminoethyl amides as a novel class of non-covalent cathepsin K inhibitorsTae-Seong Kim, Andrew B Hague, Tony I Lee, et al.
Bioorganic & Medicinal Chemistry|July 31, 1999
Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ET(A) receptor selectivityS A Boyd, R A Mantei, A S Tasker, et al.
Bioorganic & Medicinal Chemistry Letters|January 20, 2012
Isoform-selective thiazolo[5,4-b]pyridine S1P1 agonists possessing acyclic amino carboxylate head-groupsAnthony B Reed, Brian A Lanman, Susana Neira, et al.
Journal of Medicinal Chemistry|March 1, 1996
2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722M Winn, T W von Geldern, T J Opgenorth, et al.
Bioorganic & Medicinal Chemistry Letters|February 9, 2010
2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeuticsQingping Zeng, Matthew P Bourbeau, G Erich Wohlhieter, et al.
Journal of Medicinal Chemistry|September 27, 2008
3-amino-7-phthalazinylbenzoisoxazoles as a novel class of potent, selective, and orally available inhibitors of p38alpha mitogen-activated protein kinaseLiping H Pettus, Shimin Xu, Guo-Qiang Cao, et al.
Pageof 10